Albert Cha, Director at KalVista Pharmaceuticals, Inc. (KALV), bought 121,280 shares at $17.84 ($2.2M) on 2019-07-19, disclosed to the SEC on 2019-07-19.
Open-market purchase of $2.2M KALV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.93 | 220 | $4K | 0.2% |
| 2 | $16.97 | 1,060 | $18K | 0.8% |
| 3 | $17.68 | 10,320 | $182K | 8.5% |
| 4 | $17.68 | 10,320 | $182K | 8.5% |
| 5 | $17.84 | 49,680 | $886K | 41.0% |
| 6 | $17.84 | 49,680 |
| $886K |
| 41.0% |
| Total | $17.80 avg | 121,280 | $2.2M | 100% |
| Filing → |
| KALV | BUY | 2019-07-30 | $1.9M | — | Filing → |
| KALV | BUY | 2018-09-12 | $18.0M | — | Filing → |
| MNLO | BUY | 2018-01-29 | $5.0M | — | Filing → |